Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesPatients preference for subsequent therapy following secondary failure of metformin and sulphonylurea
Practical Diabetes International, 09/04/09
Khan H et al. – The authors surveyed 205 type 2 diabetic patients with glycated haemoglobin 7.5–10.0% on maximum metformin and sulphonylurea to determine their choice for further glycaemic therapy. Despite physician preference for insulin, most patients prefer additional oral agents over injectables.
Related Articles
Lactic Acidosis Associated With Metformin in a Patient With Type 2 Diabetes With No Contraindication
The Endocrinologist, 11/13/09
Relevance Score: 91%
Effects of pioglitazone and rosiglitazone combined with metformin on body weight in people with diabetes
Diabetes, Obesity and Metabolism, 11/12/09
Relevance Score: 89%
Study Finds That ONGLYZA (saxagliptin) When Added To Metformin Was Non-Inferior To JANUVIA When Added To Metformin In Reducing Hemoglobin In Adults With Type 2 Diabetes Mellitus
Bristol Myers-Squibb Company, 10/06/09
Relevance Score: 89%
Efficacy and safety of pioglitazone/metformin fixed-dose combination therapy compared with pioglitazone and metformin monotherapy in treating patients with T2DM
Current Medical Research and Opinion, 10/22/09
Relevance Score: 88%
Association of metformin, elevated homocysteine and methylmalonic acid levels, and clinically worsened diabetic peripheral neuropathy
Diabetes Care, 10/30/09
Relevance Score: 87%
Today in Diabetes...keeping you current
Receive free subspecialty "5-minute updates" via email
Consumption of restaurant foods and incidence of type 2 diabetes in African American women
American Journal of Clinical Nutrition, 12/17/09
Responses to Continuous Glucose Monitoring in Subjects with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion or Multiple Daily Injections
Diabetes Technology & Therapeutics, 12/17/09
Increased Urinary Angiotensinogen Is Precedent to Increased Urinary Albumin in Patients With Type 1 Diabetes
The American Journal of the Medical Sciences, 12/17/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Responses to Continuous Glucose Monitoring in Subjects with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion or Multiple Daily Injections
Diabetes Technology & Therapeutics, 12/17/09
Metformin Reduces Arterial Stiffness and Improves Endothelial Function in Young Women with Polycystic Ovary Syndrome: A Randomized, Placebo-Controlled, Crossover Trial
Journal of Clinical Endocrinology and Metabolism, 12/17/09
Difference in Insulin Usage Patterns with Pubertal Development in Children with Type 1 Diabetes During Transition from Multiple Daily Injections to Continuous Subcutaneous Insulin Infusion (CSII) and Through the CSII Treatment
Diabetes Technology & Therapeutics, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor